FOSETIC 20/12.5 fosinopril sodium 20 mg and hydrochlorothiazide 12.5 mg tablet bottle

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

fosinopril sodium, Quantity: 20 mg; hydrochlorothiazide, Quantity: 12.5 mg

Disponibbli minn:

Medis Pharma Pty Ltd

INN (Isem Internazzjonali):

Fosinopril sodium,Hydrochlorothiazide

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: lactose monohydrate; pregelatinised maize starch; croscarmellose sodium; glycerol dibehenate; titanium dioxide; iron oxide yellow; iron oxide red

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

30 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Mild to moderate hypertension. Treatment should not be initiated with this combination.

Sommarju tal-prodott:

Visual Identification: Light orange round tablet with "FH" on one side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2008-10-03